Inhibition of Bunyaviruses, Phleboviruses, and Hantaviruses by human MxA protein

Journal of Virology

Volumn 70, Issue 2, 1996, Pages 915-923

  Frese, Michael ^a   Kochs, Georg ^a   Feldmann, Heinz ^b   Hertkorn, Christian ^a   Haller, Otto ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GUANOSINE TRIPHOSPHATASE; INTERFERON; VIRUS RNA;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; BUNYAVIRUS; CELL STRAIN BHK; CHROMOSOME 21; CONTROLLED STUDY; ENCEPHALITIS; HANTAVIRUS; HEMORRHAGIC FEVER; LA CROSSE VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; RIFT VALLEY FEVER BUNYAVIRUS; VERO CELL; VIRUS INHIBITION; VIRUS TITRATION;

EID: 0029671215     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.2.915-923.1996     Document Type: Article

References (51)

1. Aebi, M., J. Fäh, N. Hurt, C. E. Samuel, D. Thomis, L. Bazzigher, J. Pavlovic, O. Haller, and P. Staeheli. 1989. cDNA structures and regulation of two interferon-induced human Mx proteins. Mol. Cell. Biol. 9:5062-5072.
2. Caplen, H., C. J. Peters, and D. H. L. Bishop. 1985. Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development. J. Gen. Virol. 66:2271-2277.
3. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidimum thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
4. Diaz, M. O., S. Ziemin, M. M. Le Beau, P. Pitha, S. D. Smith, R. R. Chilcote, and J. D. Rowley. 1988. Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell lines Proc. Natl. Acad. Sci. USA 85:5259-5263.
5. Feldmann, H., M. Frese, and O. Haller. Unpublished data.
6. Frese, M., G. Kochs, U. Meier-Dieter, J. Siebler, and O. Haller. 1995. Human MxA protein inhibits tick-borne Thogoto virus but not Dhori virus. J Virol 69:3904-3909.
7. Goldbach, R., and D. Peters. 1994. Possible causes of the emergence of tospovirus diseases. Semin. Virol 5:113-120.
8. Gonzalez-Scarano, F., and N. Nathanson. 1990. Bunyaviruses, p. 1195-1228. In B. N. Fields (ed.), Virology. Raven Press, New York.
9. Gonzalez-Scarano, F., R. E. Shope, C. E. Calisher, and N. Nathanson. 1982. Characterization of monoclonal antibodies against the G1 and N proteins of La Crosse and Tahyna, two California serogroup bunyaviruses. Virology 120:42-53.
10. Griot, C., F. Gonzalez-Scarano, and N. Nathanson. 1994. Molecular determinants of the virulence and infectivity of California serogroup bunyaviruses. Annu. Rev. Microbiol. 47:117-138.
11. Gui, X. N., M. Ho, M. S. Cohen, Q. L. Wang, H.-P. Huang, and Q.-X. Xie. 1987. Hemorrhagic fever with renal syndrom: treatment with recombinant α interferon. J. Infect. Dis. 155:1047-1051.
12. Gunning, P., P. Ponte, H. Okayama, J. Engel, H. Blau, and L. Kedes. 1983. Isolation and characterization of full length cDNA clones for human α, β, and γ actin mRNAs. Mol. Cell. Biol. 3:787-795.
13. Hallensleben, W. 1995. Diploma thesis. Universität Freiburg, Freiburg, Germany.
14. Huang, T., J. Pavlovic, P. Staeheli, and M. Krystal. 1992. Overexpression of the influenza virus polymerase can titrate out inhibition by the marine Mx1 protein. J. Virol 66:4154-4160.
15. Isaacs, A., J. S. Porterfield, and S. Baron. 1961. The influence of oxygenation on virus growth. II. Effect on the antiviral action of interferon. Virology 14:450-455.
16. Israel, A. 1979. Preliminary characterization of the particles from productive and abortive infections of L cells by fowl plague virus. Ann. Microbiol (Paris) 1308:85-100.
17. Jacoby, D. R., C. Cooke, I. Prabakaran, J. Boland, N. Nathanson, and F. Gonzalez-Scarano. 1993. Expression of the La Crosse M segment proteins in a recombinant vaccinia expression system mediates pH-dependent cellular fusion. Virology 193:993-996.
18. Knuth, T., H. Liebermann, and D. Urbaneck. 1990. Fur die DDR neuartige Virusinfektionen der Haustiere, 4. Mitteilung: Die Tahyna-Virusinfektion-ein Überblick. Arch. Exp. Vet. Med. 44:265-277.
19. Krug, R. M., M. Shaw, B. Broni, G. Shapiro, and O. Haller. 1985. Inhibition of influenza viral mRNA synthesis in cells expressing the interferon-induced Mx gene product. J. Virol. 56:201-206.
20. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227:680-685.
21. Landis, H., H. P. Hefti, and J. Pavlovic. Mx1 and MxA inhibit influenza virus RNA synthesis in vitro independent of the endonuclease activity of PB2. Virology, in press.
22. Laughlin, L. W., J. M. Meegan, L. H. Strausbaugh, D. M. Morens, and R. H. Watten. 1979. Epidemic Rift Valley fever in Egypt: observations of the spectrum of human illness. Trans. R. Soc. Trop. Med. Hyg. 73:630-633.
23. Morrill, J. C., G. B. Jennings, T. M. Cosgriff, P. H. Gibbs, and C. J. Peters. 1989. Prevention of Rift Valley fever in rhesus monkeys with interferon-alpha. Rev. Infect. Dis. 11:(Suppl. 4):815-825
24. Murphy, F. A., C. M. Fauquet, D. H. L. Bishop, S. A. Ghabrial, A. W. Jarvis, G. P. Martelli, M. A. Mayo, and M. D. Summers (ed.). 1995. Virus taxonomy. Springer-Verlag KG, Vienna.
25. Nathanson, N., and F. Gonzalez-Scarano. 1994. Bunyaviruses, p. 185-196. In R. G. Webster and A. Granoff (ed.), Encyclopedia of virology Academic Press Ltd., London.
26. Nichol, S. T., C. F. Spiropoulou, S. Morzunov, P. E. Rollin, T. G. Ksiazek, H. Feldmann, A. Sanchez, J. Childs, S. Zaki, and C. J. Peters. 1993. Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science 262:914-917.
27. Pavlovic, J., H. A. Arzet, H. P. Hefti, M. Frese, D. Rost, B. Ernst, E. Kolb, P. Staeheli, and O. Haller. 1995. Enhanced virus resistance of transgenic mice expressing the human MxA protein. J. Virol. 69:4506-4510.
28. Pavlovic, J., O. Haller, and P. Staeheli. 1992. Human and mouse Mx proteins inhibit different steps of the influenza virus multiplication cycle. J. Virol. 66:2564-2569.
29. Pavlovic, J., T. Zürcher, O. Haller, and P. Staeheli. 1990. Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein. J. Virol. 64:3370-3375
30. Pensiero, M. N., J. B. Sharefkin, C. W. Diefenbach, and J. Hay. 1992. Hantaan virus infection in human endothelial cells. J. Gen. Virol. 66:5929-5936.
31. Peters, C. J., J. A. Reynolds, T. W. Slone, D. E. Jones, and E. L. Stephen. 1986. Prophylaxis of Rift Valley fever with antiviral drugs, immune serum, an interferon inducer, and a macrophage activator. Antiviral Res. 6:255-297.
32. Rossier, C., J. Patterson, and D. Kolakofsky. 1986. La Crosse virus small genome mRNA is made in the cytoplasm J. Virol. 58:647-650.
33. Ruo, S. L., A. Sanchez, L. H. Elliott, L. S. Brammer, J. B. McCormick, and S. P. Fisher-Hoch. 1991. Monoclonal antibodies to three strains of hantaviruses: Hantaan, R22, and Puumala. Arch. Virol. 119:1-11.
34. Samuel, C. E. 1991. Antiviral actions of interferon. Interferon-regulated cellular proteins and their surprisingly selective antiviral activities. Virology 183:1-11.
35. Schneider-Schanlies, S., J. Schneider-Schaulies, A. Schuster, M. Bayer, J. Pavlovic, and V. ter Meulen. 1994. Cell-type-specific MxA mediated inhibition of measles virus transcription in human brain cells. J. Virol. 68:6910-6917.
36. Schnorr, J. J. S. Schneider-Schaulies, A. Simon-Jödicke, J. Pavlovic, M. A. Horisberger, and V. ter Meulen. 1993. MxA-dependent inhibition of measles virus glycoprotein synthesis in a stably transfected human monocytic cell line. J. Virol. 67:4760-4768.
37. Schwemmle, M., K. C. Weining, M. F. Richter, B. Schumacher, and P. Staeheli. 1995. Vesicular stomatitis virus transcription inhibited by purified MxA protein. Virology 206:545-554.
38. Sester, U. 1994. Ph.D. thesis. Universität Freiburg, Freiburg, Germany.
39. Staeheli, P. 1990. Interferon-induced proteins and the antiviral state. Adv Virus Res. 38:147-200.
40. Staeheli, P., and O. Haller. 1985. Interferon-induced human protein with homology to protein Mx of influenza virus-resistant mice. Mol. Cell. Biol. 5:2150-2153.
41. Staeheli, P., and O. Haller. 1987. Interferon-induced Mx protein: a mediator of cellular resistance to influenza virus. Interferon 8:1-23.
42. Staeheli, P., and J. Pavlovic. 1991. Inhibition of vesicular stomatitis virus mRNA synthesis by human MxA protein. J. Virol. 65:4498-4501.
43. Staeheli, P., F. Pitossi, and J. Pavlovic. 1993 Mx proteins: GTPases with antiviral activity. Trends Cell Biol. 3:268-272.
44. Stranden, A., P. Staeheli, and J. Pavlovic. 1993. Function of the mouse Mx1 protein inhibited by overexpression of influenza virus PB2. Virology 197:642-651.
45. Tamura, M., H. Asada, K. Kondo, M. Takahashi, and K. Yamanishi. 1987. Effects of human and murine interferons against hemorrhagic fever with renal syndrome (HFRS) virus (Hantaan virus). Antiviral Res. 8:171-178.
46. Temonen, M., I. Julkunen, and A. Vaheri. Personal communication.
47. Temonen, M., H. Lankinen, O. Vapalathi, T. Ronni, I. Julkunen, and A. Vaheri. 1995. Effect of interferon-alpha and cell differentiation on Puumula virus infection in human monocyte/macrophages. Virology 206:8-15.
48. Thimme, R., M. Frese, G. Koch's, and O. Haller. 1995 Mx1 but not MxA confers resistance against tick-borne Dhori virus in mice. Virology 210:296-301.
49. Thompson, W. H., B. Kalfayan, and R. O. Anslow. 1965. Isolation of California encephalitis group virus from a fatal human illness. Am. J. Epidemiol. 81:245-253.
50. Zhao, H., B. P. De, and A. K. Banerjee. 1995. Effect of interferon-α on the replication of human parainfluenza virus type 3, abstr. W40-10, p. 196. In 14th Annual Meeting of the American Society for Virology.
51. Zürcher, T., J. Pavlovic, and P. Staeheli. 1992. Mechanism of human MxA protein action: variants with changed antiviral properties. EMBO J. 11:1657-1661